Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema

PURPOSE: To assess the effect of twice-daily nepafenac ophthalmic suspension 0.3% on postoperative cystoid-macular-edema (CME). PATIENTS AND METHODS: In this prospective, clinic-based, non-randomized case-series, 21 patients (21 eyes) were enrolled with either acute or chronic postoperative CME afte...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Ther Clin Risk Manag
Päätekijät: Giarmoukakis, Athanassios K, Blazaki, Styliani V, Bontzos, Georgios C, Plaka, Argyro D, Seliniotakis, Konstantinos N, Ioannidi, Larissa D, Tsilimbaris, Miltiadis K
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove 2020
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7654537/
https://ncbi.nlm.nih.gov/pubmed/33192068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S271184
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia